WebJan 31, 2024 · Company: Novartis Approved: 2007 Indication (s): HER2-positive metastatic breast cancer Sales: N/A Generic (s) approved? No Patent expiration date in 2024: Sept. 29 (treatment of HER2-positive... WebMar 22, 2024 · Date of Patent: March 7, 2024 Assignee: Novartis AG Inventors: Bernhard Hubert Geierstanger, Weijia Ou, Tetsuo Uno Treatment of cancer using a CD123 chimeric antigen receptor Patent number: 11591404 Abstract: The invention provides compositions and methods for treating diseases associated with expression of CD123.
Novartis hit with $178 million verdict in cancer drug patent dispute …
WebThe disclosure provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating patients having cancer, wherein the cancer is … WebApr 30, 2024 · The three largest and best-positioned players in the mRNA space are currently Moderna, BioNTech and CureVac, each having very large patent estates, 11-figure market caps, double-digit candidates... the devil butcher full movie
Novartis AG v. Union of India & Others (Supreme Court of …
WebNov 26, 2012 · Publication number: 20130217719. Abstract: The invention provides a pharmaceutical combination comprising: a) compounds that inhibit the binding of the Smac protein to IAPs; and b) a taxane, and a method for treating or preventing a proliferative disease using such a combination. Type: Application. Webthat WRN was reduced by ≥90% throughout the 4 d after siRNA-WRN treatment (Fig. S3). WRN-depleted HeLa cells were treated with DMSO or 3 μM NSC 19630 for 0–3 d (Fig. 1B). WRN-depleted HeLa cells grown in the presence of 3 μM NSC 19630 were resistant to its antiproliferative effects, whereas control siRNA HeLa cells were highly sensitive ... WebThe present invention provides, inter alia, compositions and methods for treating various diseases and disorders in a mammal by administering to a mammal in need an effective … the devil card sideways tarot